General

Sort by Latest
What the replication crisis means for AI and drug discovery
Back in May 2016, the scientific publication Nature surveyed over 1,500 researchers to find out how...
May 4, 2023
2 min read
Single-arm clinical trials: EMA launches consultation
In contrast to randomised controlled trials (RCTs), single-arm clinical trials (SATs) are relatively...
April 26, 2023
2 min read
The Windsor Framework: One Step Closer to a Single UK market
Following the coming into force of the Windsor Agreement on 25 March 2023, we take a look at what this...
April 3, 2023
5 min read
UK Clinical Trials Changes – a Leg Up or a Step Down?
The government recently consulted on proposals intended to improve the UK’s clinical trials legislation...
April 3, 2023
2 min read
The Impact of the NIS2 Directive and the CER Directive for Medical Device Manufacturers and the Healthcare Sector
The rise in the volume of cyber incidents, the war in Ukraine, and the recent pandemic, has increased...
February 17, 2023
9 min read
Guide to EU and UK Pharmaceutical Regulatory Law 2023
Eighth Edition, Edited by Sally Shorthose The Guide to EU and UK Pharmaceutical Regulatory...
January 31, 2023
3 min read
Publication of CNIL standards on health data processing implemented in the context of early access and compassionate use authorisations
The French data protection authority (Commission Nationale de l'Informatique et des Libertés...
January 16, 2023
2 min read
Rebranding generics as branded medicines – CJEU issues new guidance
The CJEU has provided welcome new guidance on when parallel importers can rebrand generic medicines with...
December 9, 2022
5 min read
To repackage or not? Latest CJEU rulings provide guidance for parallel traders of medicines
Repackaging of medicine is a hotly debated issue between pharmaceutical companies and parallel traders....
November 22, 2022
8 min read